phenylpropanolamine has been researched along with Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YL; Feng, WJ; Zhang, XL | 1 |
Edwards, KR; O'Connor, JT | 1 |
Alberca, R; Barrero, R; Campoy, P; Cayuela, A; Mir, P; Pena, JM | 1 |
1 trial(s) available for phenylpropanolamine and Parkinson Disease
Article | Year |
---|---|
[Parkinson's disease combined with overactive bladder syndrome treated with acupuncture and medication].
Topics: Adult; Aged; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Electroacupuncture; Female; Humans; Male; Middle Aged; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2012 |
2 other study(ies) available for phenylpropanolamine and Parkinson Disease
Article | Year |
---|---|
Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Benzhydryl Compounds; Cholinesterase Inhibitors; Cresols; Delirium; Drug Interactions; Female; Humans; Male; Muscarinic Antagonists; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate | 2002 |
[Urinary symptoms and urodynamic findings in Parkinson's disease].
Topics: Aged; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2007 |